Literature DB >> 5472764

Apomorphine in Parkinsonian tremor.

J Braham, I Sarova-Pinhas, Y Goldhammer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5472764      PMCID： PMC1701616          DOI： 10.1136/bmj.3.5725.768

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  2 in total

1.  Apomorphine in Parkinson's disease.

Authors:  R S SCHWAB; L V AMADOR; J Y LETTVIN
Journal:  Trans Am Neurol Assoc       Date:  1951

2.  Similarities between neurologic effects of L-dopa and of apomorphine.

Authors:  G C Cotzias; P S Papavasiliou; C Fehling; B Kaufman; I Mena
Journal:  N Engl J Med       Date:  1970-01-01       Impact factor: 91.245
  2 in total
  11 in total

1.  The clinical use of apomorphine in Parkinson's disease.

Authors:  M J Steiger; N P Quinn; C D Marsden
Journal:  J Neurol       Date:  1992-08       Impact factor: 4.849

2.  Comparison of motor response to apomorphine and levodopa in Parkinson's disease.

Authors:  P A Kempster; J P Frankel; G M Stern; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-11       Impact factor: 10.154

Review 3.  The pharmacological and biochemical basis of neuroleptic treatment in schizophrenia.

Authors:  C J Niemegeers; J E Leysen
Journal:  Pharm Weekbl Sci       Date:  1982-06-25

4.  An evaluation of apomorphine action on doapminergic receptors.

Authors:  P C Dandiya; H L Sharma; S K Patni; R S Gambhir
Journal:  Experientia       Date:  1975-12-15

Review 5.  Role of apomorphine in the treatment of Parkinson's disease.

Authors:  Allison Boyle; William Ondo
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

6.  Therapeutical efficacy of a combination of apomorphine with sulpiride or metoclopramide in Parkinsonism.

Authors:  G U Corsini; M D Zompo; C Cianchetti; A Mangoni
Journal:  Psychopharmacologia       Date:  1976-05-28

7.  Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.

Authors:  P Ettigi; N P Nair; S Lal; P Cervantes; H Guyda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-09       Impact factor: 10.154

8.  Effects of ET 495 (piribedil) on water intake in the rat: evidence for a dopaminergic involvement in thirst.

Authors:  C T Dourish; S J Cooper
Journal:  Ir J Med Sci       Date:  1978-08       Impact factor: 1.568

9.  Pen injected apomorphine against off phenomena in late Parkinson's disease: a double blind, placebo controlled study.

Authors:  L Ostergaard; L Werdelin; P Odin; O Lindvall; E Dupont; P B Christensen; E Boisen; N B Jensen; S H Ingwersen; M Schmiegelow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-06       Impact factor: 10.154

10.  [The "off-on" phenomenon during treatment of parkinson's disease with levodopa (author's transl)].

Authors:  J Wajsbort
Journal:  J Neurol       Date:  1977-04-28       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.